Los Angeles, CA  – Calibre Scientific is pleased to announce that it has completed the acquisition of Kalon Biological Limited and Clin-Tech Limited (together “KalonBio“ or the “Company”). The Company specializes in the development and manufacture of a range of medical diagnostic kits, commercial ELISA (enzyme immunoassays [EIA]) kits and reagents for the healthcare and life sciences industry.

Kalon Biological is headquartered in Guildford, UK, and is comprised of the following brands:  KalonBio, Clin-Tech, and Microimmune. KalonBio specializes in the design and manufacture of in-vitro diagnostic (“IVD”) medical devices and commercial ELISA kits. Clin-Tech provides stains, reagents, and diagnostic kits across a broad product portfolio. And, Microimmune provides IVD products focused on measles, mumps, and rubella testing to hospitals, central testing labs and distribution partners internationally.

“This exciting acquisition adds breadth to our expanding portfolio in the life science tools and diagnostics sector,” said Dr. Ben Travis, CEO of Calibre Scientific. “The products manufactured by KalonBio mesh perfectly with our existing diagnostic platform and broaden our reach within the healthcare, research, pharmaceutical and veterinary industries.

“We remain committed to continue working closely with our customers and partners to create ever-improving analytics that give us superior vigilance against vaccine-preventable infectious diseases around the world,” stated KalonBio’s Managing Director, Dr. Michael Childerstone.

About Calibre Scientific Inc.

Calibre Scientific is a diversified global provider of life science reagents, tools, instruments, and other consumables to the lab research, diagnostics, industrial and biopharmaceutical communities. The Company is committed to pushing the boundaries of science and innovation through internal expertise combined with strategic acquisitions that help deliver a differentiated and comprehensive set of products, services and support to our customers. Calibre Scientific represents a portfolio of niche life science companies, across various key verticals, that have an unrivaled ability to address the unique challenges of their respective markets. Through a combination of acquisitions and organic growth our global reach extends into over 53 countries, empowering customers all over the world. Headquartered in Los Angeles, California, Calibre Scientific continues to grow across a wide array of verticals and geographies, further diversifying its product offering and global footprint to laboratories around the world.

For more information, visit www.calibrescientific.com,